ocu410st
·Code: RORA
ocu410st: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Ocugen, Inc. (OCGN) | Phase 2/Phase 3 |
Clinical Trials (1)
A PHASE 1 STUDY TO ASSESS THE SAFETY AND EFFICACY OF OCU410ST FOR STARGARDT DISEASE AND PHASE 2/3 PIVOTAL CONFIRMATORY CLINICAL TRIAL TO ASSESS THE SAFETY AND EFFICACY OF OCU410ST FOR STARGARDT DISEASE
Frequently asked questions
Who is developing ocu410st?
ocu410st is being developed by Ocugen, Inc..
How many clinical trials involve ocu410st?
BioSniper tracks 1 clinical trial involving ocu410st.
Get deeper analysis on ocu410st
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis